Welcome to a new report of my Dividend Diary on the TEV Blog. Here, I report the development of a cash flow-oriented investment approach that focuses on generating a passive income through dividends. Against this background, the goal is not to outperform the market but to put food on the table through a regular income via dividends.
With the Dividend Diary, I document how a cash-flow investment approach can be part of well-balanced wealth management. To keep things simple, I have built three pillars:
- Active income.
- Passive income.
- Conversion.
Dividends fall into the last two categories. They are passive because they provide a cash flow without me going to work. Additionally, they are an essential pillar for conversion since they can be reinvested to generate even more income in the future. That is the Theory. Now let’s get down to practice.
My monthly income with dividends in March:
This month, my cash-flow approach generated the following income through dividends:
- Archer Daniels Midland (12.59 EUR)
- Pfizer (31.64 EUR)
- Johnson & Johnson (18.02 EUR)
- IBM (19.87 EUR)
- Snap-on (26.00 EUR)
- 3M (32.47 EUR)
- Realty Income (14.10 EUR)
- Kontoor Brands (7.66 EUR)
- Stanley Black & Decker (11.41 EUR)
- Unilever (41.19 EUR)
- Qualcomm (21.34 EUR)
- Novo Nordisk (17.52 EUR)
- Imperial Brands (13.99 EUR)
- Broadcom (25.11 EUR)
- PepsiCo. (14.35 EUR).
The total monthly income with dividends in March (after taxes) was: € 307.24 / appr. $ 333
Dividend income report check
Solid performance compared to last year (+ 20 percent YoY).
Sales in March
I sold all of my 25 Kontoor Brands and 75 HP Inc. shares.
Stock purchases in March
In March, I bought more shares of great companies so that the monthly income through dividends will continue to rise. As I implemented a few saving plans, I invested in much more companies than usual:
- Emerging Markets ETF
- Japan ETF (newly implemented)
- Mayr-Melnhof Karton
- Snap-on (newly implemented)
- General Dynamics
- Valmet
- CVS Health
- Diageo
- Teamviewer
- Henkel
- Mensch & Maschine
- USU Software
- Stemmer Imaging
- AbbVie
- Automatic Data Processing
- Bristol-Myers Squibb
- Cisco Systems
- Generals Mills
- IBM
- Pfizer
- Qualcomm
- Realty Income.
